OrbiMed
Biopharmaceutical Diagnostics Disease Management Drug Discovery Healthcare

Business Overview

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.

We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Life Sciences Focus

The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease. These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. The healthcare industry’s powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.

Founded
2010
Investor type
Venture Capital
Business model preference
B2B, B2C
Series preference
Series A, Series B, Series C, Series D
Capital raised
$15,000,000,000
Cheque size
Min: $5.3M
Offering preference
Hardware, Software
AI type preference
Artificial Intelligence, Computer Vision, Deep Learning, Machine Learning, Natural Language Processing, Robotics
Sectors
Biopharmaceutical Diagnostics Disease Management Drug Discovery Healthcare HomeCare Life sciences Lifestyle Management Medical Imaging Prevention Synthetic Data

Team

OrbiMed
Anat Naschitz
Managing Director
OrbiMed
Nissim Darvish
Sr. Managing Director

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

BiomX
Merged
Software
B2B
$56 M
1
Emendo Biotherapeutics
Acquired
$61 M
4
MDClone
Active
Software
B2B
$41 M
4

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

September 2020
Series C
$57 M
View All Investors (11 Total)
August 2020
Series C
$4 M
View All Investors (4 Total)
April 2020
Series D
$50 M
View All Investors (7 Total)

Funds Raised

Date Announced

Fund Number

Amount Raised

May 2016
2
$307M
March 2011
1
$203M

Similar Investors

TYPE
Venture Capital
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
TYPE
Venture Capital
TYPE
Venture Capital
TYPE
Venture Capital
TYPE
Company
TYPE
Venture Capital
MIN CHEQUE
$0.32 M
TYPE
Company
TYPE
Investment Firm
TYPE
Foundation
TYPE
Venture Capital
TYPE
Venture Capital
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
TYPE
Venture Capital
TYPE
Venture Capital
TYPE
Corporate Venture Capital
TYPE
Venture Capital

CONTACT

89 Medinat HaYehudim St Building E, 11th Floor 4614001 Herzliya Israel

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month